Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

Somatostatinoma

Johannes Czernin – Somatostatinoma

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors Ga-DOTATOC Versus Octreoscan + CT Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer